Partner Content Partner Content DTC Genetic Testing Market will cross $2,500 million by 2025 DTC Genetic Testing Market will achieve 15%+ CAGR
Oncology Liver cancer diagnostic gets FDA breakthrough status, with P... Mursla Bio CEO and founder Pierre Arséne discusses the breakthrough designation from the FDA for their blood test to catch liver cancer early.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face